Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

SHA:603567 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,984	10,897	11,423	11,988	14,412	9,477
Market Cap Growth	-24.46%	-4.61%	-4.71%	-16.82%	52.08%	-12.40%
Enterprise Value	11,068	13,767	13,636	13,478	17,271	11,076
Last Close Price	8.50	11.46	11.80	12.35	14.68	10.71
PE Ratio	-	24.87	24.16	64.65	43.40	21.72
Forward PE	-	36.69	36.69	36.69	36.69	36.69
PS Ratio	5.01	4.03	3.64	2.85	3.49	2.78
PB Ratio	1.10	1.31	1.42	1.69	2.04	1.72
P/TBV Ratio	1.28	1.60	1.69	1.90	2.12	1.80
P/FCF Ratio	21.42	-	-	-	-	-
P/OCF Ratio	14.27	66.32	-	-	-	61.07
EV/Sales Ratio	6.94	5.09	4.35	3.20	4.18	3.25
EV/EBITDA Ratio	-	18.19	37.43	-	42.55	14.94
EV/EBIT Ratio	-	22.83	73.50	-	63.88	18.92
EV/FCF Ratio	29.69	-	-	-	-	-
Debt / Equity Ratio	0.45	0.40	0.39	0.41	0.42	0.58
Debt / EBITDA Ratio	-	4.32	8.38	-	7.23	4.33
Debt / FCF Ratio	8.84	-	-	-	-	-
Asset Turnover	0.13	0.22	0.26	0.36	0.38	0.35
Inventory Turnover	0.70	1.21	2.14	4.07	3.34	1.80
Quick Ratio	1.22	2.11	2.16	1.27	2.04	1.92
Current Ratio	1.76	2.85	2.60	1.65	2.37	2.66
Return on Equity (ROE)	-4.32%	5.34%	6.17%	2.70%	5.30%	8.14%
Return on Assets (ROA)	-0.87%	2.99%	0.96%	-1.17%	1.55%	3.80%
Return on Invested Capital (ROIC)	-1.61%	4.97%	1.94%	-1.59%	2.54%	7.59%
Return on Capital Employed (ROCE)	-2.10%	5.90%	1.90%	-2.80%	3.10%	7.30%
Earnings Yield	-4.17%	4.02%	4.14%	1.55%	2.30%	4.60%
FCF Yield	4.67%	-0.23%	-5.02%	-6.10%	-6.12%	-7.53%
Dividend Yield	1.74%	1.31%	1.70%	0.23%	0.72%	-
Payout Ratio	-	74.00%	33.48%	131.34%	43.28%	76.15%
Buyback Yield / Dilution	0.12%	0.01%	0.14%	-8.87%	-1.82%	0.01%
Total Shareholder Return	1.83%	1.31%	1.83%	-8.64%	-1.10%	0.01%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.